These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32460417)

  • 21. Neurologists and COVID-19: A note on courage in a time of uncertainty.
    Shellhaas RA
    Neurology; 2020 May; 94(20):855-857. PubMed ID: 32238504
    [No Abstract]   [Full Text] [Related]  

  • 22. Differences in presentation, severity and management of DKA in type 1 and type 2 diabetes during the COVID-19 pandemic.
    Wallett L; Kempegowda P; Melson E; Juszczak A; Thomas L; Zhou D; Holmes C; Karamat MA; Ghosh S; Hanif W; Johnson A; Narendran P; Bellary S
    Clin Med (Lond); 2021 Mar; 21(Suppl 2):1-2. PubMed ID: 34078672
    [No Abstract]   [Full Text] [Related]  

  • 23. Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532.
    Maahs DM; Alonso GT; Gallagher MP; Ebekozien O
    Diabetes Care; 2021 May; 44(5):e102. PubMed ID: 33972320
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532.
    Gregory JM; Slaughter JC; Duffus SH; Smith TJ; LeStourgeon LM; Jaser SS; McCoy AB; Luther JM; Giovannetti ER; Boeder S; Pettus JH; Moore DJ
    Diabetes Care; 2021 May; 44(5):e103-e104. PubMed ID: 33972321
    [No Abstract]   [Full Text] [Related]  

  • 25. Diabetes and COVID-19.
    Bloomgarden ZT
    J Diabetes; 2020 Apr; 12(4):347-348. PubMed ID: 32162476
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic.
    Kow CS; Hasan SS
    Obes Surg; 2021 Jan; 31(1):413-414. PubMed ID: 32583299
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know.
    Paybast S; Emami A; Koosha M; Baghalha F
    Acta Neurol Taiwan; 2020 Mar; 29(1)():24-31. PubMed ID: 32285431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia.
    Moin ASM; Al-Qaissi A; Sathyapalan T; Atkin SL; Butler AE
    Metabolism; 2021 Jan; 114():154417. PubMed ID: 33157081
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19: A Review for the Pediatric Neurologist.
    Christy A
    J Child Neurol; 2020 Nov; 35(13):934-939. PubMed ID: 32660309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention.
    Gęca T; Wojtowicz K; Guzik P; Góra T
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner.
    Valderas C; Méndez G; Echeverría A; Suarez N; Julio K; Sandoval F
    World J Pediatr; 2022 Jun; 18(6):373-382. PubMed ID: 35476245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists.
    Jin H; Hong C; Chen S; Zhou Y; Wang Y; Mao L; Li Y; He Q; Li M; Su Y; Wang D; Wang L; Hu B
    Stroke Vasc Neurol; 2020 Jun; 5(2):146-151. PubMed ID: 32385132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 and neurological training in Europe: from early challenges to future perspectives.
    van der Meulen M; Kleineberg NN; Schreier DR; García-Azorin D; Di Lorenzo F
    Neurol Sci; 2020 Dec; 41(12):3377-3379. PubMed ID: 32970238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Covid-19 and diabetes].
    Paquot N; Radermecker RP
    Rev Med Liege; 2020 Sup; 75(S1):138-145. PubMed ID: 33211437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nervous system-A new territory being explored of SARS-CoV-2.
    Zhang M; Zhou L; Wang J; Wang K; Wang Y; Pan X; Ma A
    J Clin Neurosci; 2020 Dec; 82(Pt A):87-92. PubMed ID: 33317745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review.
    Deravi N; Fathi M; Vakili K; Yaghoobpoor S; Pirzadeh M; Mokhtari M; Fazel T; Ahsan E; Ghaffari S
    Rev Cardiovasc Med; 2020 Sep; 21(3):385-397. PubMed ID: 33070543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis.
    Pinto LC; Bertoluci MC
    Arch Endocrinol Metab; 2020; 64(3):199-200. PubMed ID: 32555985
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.
    Naughton SX; Raval U; Pasinetti GM
    J Alzheimers Dis; 2020; 76(1):21-25. PubMed ID: 32538855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 2 diabetic Asian Indians and COVID-19: Lessons learnt so far from the ongoing pandemic.
    Shivane VK; Lila AR; Bandgar TR
    J Postgrad Med; 2020; 66(4):179-181. PubMed ID: 33037170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.